(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RILENTO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RILENTO

ST13

US500000088437558

Class

42

Filing

88437558

Registration

5926086

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

03/25/2025

Trademark type

Word

Nice classes

42

Filing date

05/20/2019

Registration date

12/03/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/24/2025

Last transaction

03/25/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

07/07/2017

First use in commerce

07/14/2017

Drawing code

4

Owner type

16

Owner location

Raleigh, NC

Examiner

BEDNARZ,DUSTIN THOMAS

Current location

Historical data usage

Holders and representatives

Holders

Rilento Pharma, LLC

Representatives

Devon E. White WYRICK ROBBINS YATES & PONTON LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development in the field of pain management; research and development in the field of sustained drug delivery; research and development in the field of drug encapsulation; research and development in the field of dental and oral surgery devices; research and development in the field of combination medical devices; research and development in the field of targeted drug therapy; pharmaceutical research and development; research and development in the field of micro-compounding; research and development in the field of pharmacokinetics; Providing research information in the field of pain managementsustained drug deliverydrug encapsulationdental and oral surgery devices

Publications

History of USPTO decisions and trademark events.

19 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/24/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/24/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/24/2025

E815

TEAS SECTION 8 & 15 RECEIVED

12/04/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/03/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/03/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/03/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/17/2019

PUBO

PUBLISHED FOR OPPOSITION

09/17/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/28/2019

ALIE

ASSIGNED TO LIE

08/15/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/08/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

08/08/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/08/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

08/08/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/08/2019

DOCK

ASSIGNED TO EXAMINER

08/07/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/04/2019

NWAP

NEW APPLICATION ENTERED

05/23/2019

Continuous trademark protection

Get notified about every new filing that threatens RILENTO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.